Prevalence of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy: evolution over 12 years and predictors
Open Access
- 16 July 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 64 (3), 607-615
- https://doi.org/10.1093/jac/dkp246
Abstract
Transmitted HIV-1 drug resistance (TDR) can reduce the efficacy of first-line antiretroviral therapy. A retrospective analysis was performed to assess the prevalence and correlates of TDR in Italy over time. TDR was defined as the presence of at least one of the mutations present in the surveillance drug resistance mutation (SDRM) list. Among 1690 antiretroviral therapy-naive patients, the most frequent HIV subtypes were B (78.8%), CRF02_AG (5.6%) and C (3.6%). Overall, TDR was 15%. TDR was 17.3% in subtype B and 7.0% in non-B carriers (P < 0.001). TDR showed a slight, although not significant, decline (from 16.3% in 1996–2001 to 13.4% in 2006–07, P = 0.15); TDR declined for nucleoside reverse transcriptase inhibitors (from 13.1% to 8.2%, P = 0.003) but remained stable for protease inhibitors (from 3.7% to 2.5%, P = 0.12) and non-nucleoside reverse transcriptase inhibitors (from 3.7% to 5.8%). TDR to any drug was stable in B subtype and showed a decline trend in non-B. In multivariable analysis, F1 subtype or any non-B subtype, compared with B subtype, and higher HIV RNA were independent predictors of reduced odds of TDR. Prevalence of TDR to nucleoside reverse transcriptase inhibitors seems to have declined in Italy over time. Increased prevalence of non-B subtypes partially justifies this phenomenon.Keywords
This publication has 32 references indexed in Scilit:
- Transmission networks of drug resistance acquired in primary/early stage HIV infectionAIDS, 2008
- Transmission of drug-resistant HIV-1 in Europe remains limited to single classesAIDS, 2008
- Prevalence and Epidemiology of HIV Type 1 Drug Resistance among Newly Diagnosed Therapy-Naive Patients in Belgium from 2003 to 2006AIDS Research and Human Retroviruses, 2008
- The Incidence of HIV Drug Resistance and Its Impact on Progression of HIV Disease Among Antiretroviral-Naïve Participants Started on Three Different Antiretroviral Therapy StrategiesHIV Research & Clinical Practice, 2007
- High Rates of Forward Transmission Events after Acute/Early HIV‐1 InfectionThe Journal of Infectious Diseases, 2007
- Emergence of Antiretroviral Therapy Resistance-Associated Primary Mutations Among Drug-Naive HIV-1-Infected Individuals in Rural Western CameroonJAIDS Journal of Acquired Immune Deficiency Syndromes, 2006
- Primary HIV Drug Resistance and Efficacy of First-Line Antiretroviral Therapy Guided by Resistance TestingJAIDS Journal of Acquired Immune Deficiency Syndromes, 2006
- Prevalence of Drug‐Resistant HIV‐1 Variants in Untreated Individuals in Europe: Implications for Clinical ManagementThe Journal of Infectious Diseases, 2005
- French National Sentinel Survey of Antiretroviral Drug Resistance in Patients With HIV-1 Primary Infection and in Antiretroviral-Naive Chronically Infected Patients in 2001-2002JAIDS Journal of Acquired Immune Deficiency Syndromes, 2005
- Primary Genotypic and Phenotypic HIV-1 Drug Resistance in Recent Seroconverters in MadridJAIDS Journal of Acquired Immune Deficiency Syndromes, 2001